- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | D-Luciferin, Sodium Salt |
| Catalog No. | RESK-0256 |
| Description | D-Luciferin sodium salt is a widely used substrate of firefly luciferase, applied throughout biotechnology and especially in in vivo bioluminescence imaging (BLI). In the presence of ATP and luciferase, the substrate is oxidized and emits light; when luciferin is in excess, the number of emitted photons is positively correlated with the luciferase concentration. Cells transfected with a plasmid carrying the luciferase gene (Luc) can be introduced into research animals such as mice and rats; after substrate injection, changes in light intensity are detected by BLI, enabling real-time monitoring of disease progression or the therapeutic efficacy of drugs. The reaction can also be used to indicate energy status or vital signs through the influence of ATP on the reaction system. |
| Intended Use | In vivo bioluminescence imaging (BLI) in small animals In vitro luciferase reporter gene assays Microbial and viral monitoring Pyrosequencing ATP-based indication of energy status or vital signs |
| Principle / Technology | In the presence of ATP and firefly luciferase, D-luciferin (substrate) is oxidized and emits light. When the substrate is in excess, the emitted photon output is directly proportional to the luciferase concentration. The reaction is chemiluminescent and requires no excitation light; the emission wavelength of firefly luciferin is 560 nm. |
| Detection Method | Bioluminescence detection (no excitation light required; emission at 560 nm for firefly luciferin). The signal can be measured with a luminometer, scintillation counter, or an in vivo small-animal imaging system equipped with a bioluminescence module. A multifunctional microplate reader can be used only after confirming with the manufacturer that a luminescence detection module is installed (fluorescence microscopes cannot be used). |
| Sample Type | Luciferase-expressing cells (e.g., Luc-transduced tumor cells); research animals such as mice and rats carrying luciferase-expressing cells for in vivo imaging. |
| Performance Range / Specifications | Appearance: pale yellow powder Solubility: soluble in water up to 100 mg/mL Purity (HPLC): >=95.0% CAS No.: 103404-75-7 Molecular formula: NaC11H7N2O3S2 · H2O Molecular weight: 302.3 g/mol |
| Specificity | Substrate of firefly luciferase. The compound is identical to products named firefly luciferin or beetle luciferin: (S)-2-(6-hydroxy-2-benzothiazolyl)-2-thiazoline-4-carboxylic acid. |
| Reaction Conditions / Protocol | Route of administration: intraperitoneal (i.p.) or tail-vein injection Suggested initial dose (from literature): 150 mg substrate per kg mouse body weight; e.g., 10 mice of 22-25 g require 33-37.5 mg of substrate Kinetics after i.p. injection in mice: luciferase-expressing cells begin to emit light about 3 min post-injection; signal reaches a stable maximum at about 10 min, remains at the peak plateau for 10-15 min, then decays; detection is recommended within 10-15 min post-injection A pilot experiment to establish the luciferase kinetic curve is recommended to determine the optimal signal detection time and plateau |
| Components / Formulation | D-Luciferin sodium salt monohydrate, supplied as a powder. |
| Storage Conditions | Store at -20 °C in a dry place, protected from light. |
| Shelf Life | 2 years when stored at -20 °C, dry and protected from light. |
| Package Specifications | 100 mg 500 mg 1 g 5 g 10 g |
| Product Form | Pale yellow powder |
| Quality Control | Purity verified by HPLC (>=95.0%). |
| Purity | >=95.0% (HPLC) |
| Concentration | Soluble in water up to 100 mg/mL. For in vivo imaging, a dilution of 1 g into 25 mL buffer is a standard preparation; the working dose in mice is typically 150 mg/kg body weight. |
| Molecular Weight | 302.3 g/mol |
| Source / Origin | CAS No. 103404-75-7. Synonyms: (S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic acid sodium salt; D-Luciferin firefly, sodium salt monohydrate. |
| Expiration Date / Stability | Powder stored protected from light at -20 °C or -70 °C is stable for at least 1 year; the labeled shelf life is 2 years at -20 °C (dry, protected from light). |
| Compatibility | The substrate readily crosses the blood-brain barrier, the placental barrier and the blood-testis barrier, and can enter living cells. The sodium salt dissolves in water up to 100 mg/mL (the potassium salt up to 60 mg/mL; the free acid is poorly soluble in water). Salt forms are convenient to use and show lower reaction toxicity in in vivo imaging experiments. |
| Recommended Buffer System | Dissolve in water or a physiologically compatible buffer. For in vitro imaging, dilute the probe in cell culture medium supplemented with ATP and Mg2+; intracellular ATP and Mg2+ are usually sufficient to drive the reaction in most cell types. |
| Application Notes / Precautions | Protect from light during storage and handling. Establish a luciferase kinetic curve in a pilot experiment to define the peak signal time and plateau. Successful in vivo imaging requires expression of the luciferase gene in the target tissue or cells, successful substrate injection, and consideration of tissue thickness at the luminescent site; if no signal is observed, check these factors. Higher substrate purity (>=99%) is recommended, since impurities may inhibit intracellular enzymes and could reduce experimental performance or harm animals. |
For research use only, not for clinical use.
|
There is no product in your cart. |